Home / Market News / $BOLT

$BOLT news and market catalysts

The 4 most recent market catalysts affecting $BOLT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

4 catalysts 3 high impact 2 bullish 2 bearish Biotechnology
Nov 13, 2026 Corporate Catalyst Bullish Impact 95
Bolt Biotherapeutics Reports Q3 2026 Financial Results and Business Update
Bolt Biotherapeutics has undergone a transformative event by acquiring Prana Therapies through a reverse merger and securing $120 million in financing. This not only provides subst…
Oct 24, 2026 Corporate Catalyst Bullish Impact 95
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Private Placement
Bolt Biotherapeutics' acquisition of Prana Therapies is a significant strategic move, immediately expanding its therapeutic pipeline with clinical-stage assets. The concurrent $120…
Aug 12, 2026 Corporate Catalyst Bearish Impact 75
Bolt Biotherapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
The headline indicates a significant negative corporate catalyst for Bolt Biotherapeutics. Worse-than-expected financial results often lead to immediate stock price declines as inv…
Aug 11, 2026 Corporate Catalyst Bearish Impact 95
Bolt Biotherapeutics Q2 EPS $(4.57) Misses $(2.88) Estimate, Sales $5.000K Miss $500.000K Estimate
Bolt Biotherapeutics' Q2 earnings report reveals a substantial underperformance, with both EPS and sales falling far short of analyst expectations. The 99.00% sales miss and 99.72%…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.